Somerset Trust’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $957K | Sell |
3,802
-120
| -3% | -$25.8K | 0.27% | 74 |
|
|
2026
Q1 | $853K | Buy |
3,922
+6
| +0.2% | +$1.33K | 0.26% | 74 |
|
|
2025
Q4 | $895K | Buy |
3,916
+24
| +0.6% | +$5.47K | 0.27% | 69 |
|
|
2025
Q3 | $901K | Buy |
3,892
+26
| +0.7% | +$5.29K | 0.28% | 66 |
|
|
2025
Q2 | $718K | Buy |
3,866
+86
| +2% | +$16K | 0.23% | 72 |
|
|
2025
Q1 | $792K | Buy |
3,780
+499
| +15% | +$97K | 0.28% | 66 |
|
|
2024
Q4 | $583K | Buy |
3,281
+584
| +22% | +$107K | 0.22% | 77 |
|
|
2024
Q3 | $533K | Buy |
2,697
+19
| +0.7% | +$3.55K | 0.2% | 84 |
|
|
2024
Q2 | $459K | Buy |
2,678
+735
| +38% | +$122K | 0.19% | 91 |
|
|
2024
Q1 | $354K | Buy |
1,943
+153
| +9% | +$26.4K | 0.14% | 103 |
|
|
2023
Q4 | $277K | Sell |
1,790
-349
| -16% | -$50.9K | 0.12% | 116 |
|
|
2023
Q3 | $319K | Buy |
2,139
+186
| +10% | +$27.3K | 0.15% | 110 |
|
|
2023
Q2 | $263K | Sell |
1,953
-12
| -0.6% | -$1.76K | 0.11% | 124 |
|
|
2023
Q1 | $313K | Sell |
1,965
-286
| -13% | -$43.7K | 0.14% | 110 |
|
|
2022
Q4 | $364K | Buy |
2,251
+60
| +3% | +$9.2K | 0.15% | 92 |
|
|
2022
Q3 | $294K | Buy |
2,191
+20
| +0.9% | +$2.87K | 0.14% | 109 |
|
|
2022
Q2 | $333K | Buy |
2,171
+133
| +7% | +$20.3K | 0.15% | 99 |
|
|
2022
Q1 | $330K | Buy |
2,038
+37
| +2% | +$5.38K | 0.13% | 105 |
|
|
2021
Q4 | $271K | Buy |
+2,001
| New | +$236K | 0.1% | 129 |
|
|
2019
Q2 | – | Sell |
-299
| Closed | -$24K | – | 103 |
|
|
2019
Q1 | $24K | Buy |
+299
| New | +$24.5K | 0.01% | 156 |
|
|
2018
Q3 | – | Sell |
-432
| Closed | -$40K | – | 172 |
|
|
2018
Q2 | $40K | Hold |
432
| – | – | 0.02% | 117 |
|
|
2018
Q1 | $41K | Hold |
432
| – | – | 0.02% | 124 |
|
|
2017
Q4 | $42K | Hold |
432
| – | – | 0.02% | 125 |
|
|
2017
Q3 | $38K | Hold |
432
| – | – | 0.02% | 125 |
|
|
2017
Q2 | $31K | Hold |
432
| – | – | 0.02% | 129 |
|
|
2017
Q1 | $28K | Hold |
432
| – | – | 0.02% | 133 |
|
|
2016
Q4 | $27K | Hold |
432
| – | – | 0.02% | 131 |
|
|
2016
Q3 | $27K | Hold |
432
| – | – | 0.02% | 133 |
|
|
2016
Q2 | $27K | Hold |
432
| – | – | 0.02% | 133 |
|
|
2016
Q1 | $25K | Hold |
432
| – | – | 0.02% | 132 |
|
|
2015
Q4 | $26K | Hold |
432
| – | – | 0.02% | 139 |
|
|
2015
Q3 | $24K | Hold |
432
| – | – | 0.02% | 142 |
|
|
2015
Q2 | $29K | Hold |
432
| – | – | 0.02% | 144 |
|
|
2015
Q1 | $25K | Hold |
432
| – | – | 0.02% | 149 |
|
|
2014
Q4 | $28K | Hold |
432
| – | – | 0.02% | 147 |
|
|
2014
Q3 | $25K | Hold |
432
| – | – | 0.02% | 150 |
|
|
2014
Q2 | $24K | Hold |
432
| – | – | 0.02% | 151 |
|
|
2014
Q1 | $22K | Hold |
432
| – | – | 0.02% | 154 |
|
|
2013
Q4 | $23K | Buy |
+432
| New | +$21.2K | 0.02% | 155 |
|
Other funds holding ABBV
Somerset Trust's ABBV Position: Q2 2026 in Review
Somerset Trust reduced its AbbVie (ABBV) stake by 3.1% in Q2 2026, selling an estimated $25.8K and leaving 3,802 shares worth $957K. The position accounts for 0.27% of the portfolio, ranked #74.
Somerset Trust first reported a position in ABBV in Q4 2013 and has held it in 39 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Somerset Trust held 3,802 shares of AbbVie worth $957K as of Q2 2026.
- Somerset Trust sold 120 AbbVie shares in Q2 2026, an estimated $25.8K.
- AbbVie made up 0.27% of Somerset Trust's portfolio in Q2 2026, its #74 holding.
- Somerset Trust first reported a position in AbbVie in Q4 2013 and has held it in 39 quarters since.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Somerset Trust's 13F filing for Q2 2026, filed 6 Jul 2026.